Response-Based Ponatinib Dose Reduction a Win-Win in Chronic-Phase CML?
(MedPage Today) -- For patients with chronic-phase chronic myeloid leukemia (CML), a response-based dose-reduction strategy for ponatinib (Iclusig) may limit its toxicity while maintaining or improving efficacy, a retrospective study suggested... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - September 29, 2022 Category: Hematology Source Type: news

Why Can't UK Immunocompromised Patients Get Evusheld? Why Can't UK Immunocompromised Patients Get Evusheld?
Professor David Kerr discusses the controversy in the United Kingdom surrounding access to Evusheld.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 29, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Cancer Deaths Due to COVID-19 Explored in March to December 2020
THURSDAY, Sept. 29, 2022 -- From March to December 2020, more than 16,500 deaths occurred in cancer patients with complications of COVID-19, according to a research letter published online Sept. 29 in JAMA Oncology. Xuesong Han, Ph.D., from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 29, 2022 Category: Pharmaceuticals Source Type: news

FDA and VHA launch medical technology collaboration
The U.S. Food and Drug Administration (FDA) and the Veterans Health Administratio...Read more on AuntMinnie.comRelated Reading: FDA finalizes guidance for clinical decision support FDA issues alert on cancers near implant scar tissue Imaging exams land on list of low-value care in VA system FDA releases guidelines on remote assessments Almost a third of veterans don't get lung cancer screening follow-up (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 29, 2022 Category: Radiology Source Type: news

1 in 5 Young Women Has No Plans to Get a Mammogram
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - September 29, 2022 Category: Cancer & Oncology Tags: Gynecology, Oncology, Radiology, Preventive Medicine, News, Source Type: news

Could Your Patients Benefit? New Trials in Noncolorectal GI Cancer Could Your Patients Benefit? New Trials in Noncolorectal GI Cancer
Several studies in noncolorectal GI cancers have started enrolling recently. Here ' s the 411 on those trials.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 29, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Switch from smoking to vaping cuts health risks substantially, report finds
Review of 400 published studies stresses vaping is not risk-free and urges action to reduce teenage useVaping is substantially less harmful than smoking, according to a major review of nicotine products, but action is needed to tackle the sharp rise in e-cigarette use among children.Researchers at King ’s College London said smokers who switched to vaping would experience a “substantial reduction” in their exposure to toxic substances that cause cancer, lung and cardiovascular disease, but they strongly urged non-smokers not to take up either habit.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - September 29, 2022 Category: Science Authors: Ian Sample Science editor Tags: Smoking E-cigarettes Health Medical research England Science Society UK news Source Type: news

Smoking Costs U.S. Economy Almost $900 Billion a Year
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - September 29, 2022 Category: Cancer & Oncology Tags: Family Medicine, Oncology, Preventive Medicine, News, Source Type: news

Making lab-grown brain organoids ‘brainier’
Key takeaways:In recent years, mini –brain organoids have been used in the lab to model a variety of diseases, from Alzheimer’s to COVID-19.With no standard process for creating these organoids, some more accurately mimic thebrain ’s structurethan others, which can lead to inconsistent scientific findings.A new studyoffers guidelines and methods for consistently generating high-quality, well-structured organoids.By using stem cells to grow miniature brain-like organs in the lab, scientists have opened a new avenue for studies of neurological development, disease and therapies that can ’t be conducted in living peop...
Source: UCLA Newsroom: Health Sciences - September 29, 2022 Category: Universities & Medical Training Source Type: news

Delphinus raises $30M to commercialize SoftVue system
Tomographic ultrasound technology developer Delphinus Medical Technologies ha...Read more on AuntMinnie.comRelated Reading: Karmanos Cancer Institute installs Delphinus' 3D breast ultrasound Delphinus gets FDA nod for 3D whole-breast US system Delphinus appoints Brem to board of directors Delphinus launches SoftVue clinical study Delphinus taps new VP of engineering (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 29, 2022 Category: Radiology Source Type: news

A New Approach to Spotting Tumors: Look for Their Microbes
New research is revealing that cancer is rife with bacteria and fungi — a rich ecosystem that scientists call the tumor microbiome. (Source: NYT Health)
Source: NYT Health - September 29, 2022 Category: Consumer Health News Authors: Carl Zimmer Tags: Microbiology Tumors Research Bacteria Cancer DNA (Deoxyribonucleic Acid) your-feed-science Source Type: news

A Devious Cellular Trick Cancers Can Use to Escape Your Immune System
A researcher discovered that giant cells under a microscope were actually cancer cells hiding inside other cancer cells. (Source: NYT Health)
Source: NYT Health - September 29, 2022 Category: Consumer Health News Authors: Gina Kolata Tags: Cancer Immune System Research Immunotherapy eLife (Journal) your-feed-science your-feed-health Source Type: news

Advanced and Metastatic NSCLC: Lessons From Patients Beyond the Classroom Advanced and Metastatic NSCLC: Lessons From Patients Beyond the Classroom
Angela Christine Argento, MD, reflects on the relative benefits of education and experience in the treatment of patients with advanced non-small cell lung cancer.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 29, 2022 Category: Consumer Health News Tags: Pulmonary Medicine MDAngle Source Type: news

Cost Paramount When Choosing Metastatic Breast Cancer Treatment Cost Paramount When Choosing Metastatic Breast Cancer Treatment
Differences in outcomes and quality of life across commonly used treatments for endocrine-refractory and triple-negative metastatic breast cancer were"razor-thin," leaving cost as a key factor.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 29, 2022 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Treatment of Advanced and Metastatic NSCLC: The Rise of the Personalized Approach to Patients Treatment of Advanced and Metastatic NSCLC: The Rise of the Personalized Approach to Patients
Benjamin Levy, MD, offers points of advice to new clinicians regarding emerging patient-centered values in the treatment of advanced non-small cell lung cancer.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 29, 2022 Category: Consumer Health News Tags: Hematology-Oncology MDAngle Source Type: news